Table 3.
The comparison of fatty acid profiles of the HFD group and HFD + EPA group.
| Annotation | Average HFD | Average HFD + EPA | Ratio (HFD + EPA/HFD) | p-value |
|---|---|---|---|---|
| myristate;14:0 | 39864 | 34970 | 0.88 | 0.53807 |
| pentadecanoate;15:0 | 12806 | 13974 | 1.09 | 0.53512 |
| palmitoleate;(Z)16:1n-7 | 40622 | 39112 | 0.96 | 0.81455 |
| palmitate;16:0 | 938375 | 853716 | 0.91 | 0.26272 |
| margarate;17:0 | 19084 | 19255 | 1.01 | 0.93569 |
| ganma-linolenate;(Z)18:3n-6 | 20128 | 21848 | 1.09 | 0.75504 |
| linoleate;(Z)18:2n-6 | 129876 | 124029 | 0.95 | 0.78848 |
| petroselate;(Z)18:1n-12 | 2211886 | 2037043 | 0.92 | 0.46729 |
| oleate;(Z)18:1n-9 | 454157 | 420540 | 0.93 | 0.48662 |
| elaidate;(E)18:1n-9 | 38177 | 35555 | 0.93 | 0.53645 |
| cis-12-Octadecenoate;(Z)18:1n-6 | 38177 | 35555 | 0.93 | 0.53645 |
| stearate;18:0 | 318521 | 286353 | 0.90 | 0.03838 |
| nonadecanoate;19:0 | 12130 | 11822 | 0.97 | 0.35015 |
| arachidonate;(Z)20:4n-6 | 28383 | 22023 | 0.78 | 0.01977 |
| cis-5,8,11,14,17-Eicosapentaenoate;(Z)20:5n-3 | n.a. | 6140 | n.a. | n.a. |
| eicosa-8,11,14-trienoate;20:3n-6 | 7323 | 4131 | 0.56 | 0.00035 |
| cis-11,14-Icosadienoate;(Z)20:2n-6 | 2134 | 1616 | 0.76 | 0.02649 |
| cis-11-icosenoate;(Z)20:1n-9 | 58754 | 42155 | 0.72 | 0.01358 |
| arachisate;20:0 | 5012 | 4983 | 0.99 | 0.94864 |
| cis-4,7,10,13,16,19-Docosahexaenoate;(Z)22:6n-3 | 18472 | 51708 | 2.80 | 8.7E-05 |
| cis-7,10,13,16,19-docosapentaenoate;(Z)22:5n-3 | 7977 | 14485 | 1.82 | 0.00157 |
The relative areas of the peaks are shown. The ratio represents the values for the HFD + EPA group to the values for the HFD group. A significant difference (p < 0.05) or (p < 0.01) is shown by one underline or two underlines. The ratio column is indicated by font that is underlined (increased; p < 0.05), bold (increased; p < 0.01), italic and underlined (decreased; p < 0.05) and italic and bold (decreased; p < 0.01).